Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Clinical trial NCT00501891 · COMPLETED

Trial details

NCT number: NCT00501891
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2007-07-01
Primary completion: 2007-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.